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Abstract. The proportion of imported malaria cases due to immigrants in Europe has increased 
during the lasts decades, with higher rates associated with settled immigrants who travel to visit 
friends and relatives (VFRs) in their country of origin. Cases are mainly 
Sub-Saharan Africa is the most common origin. Clinically, malaria in immigrants is characterised 
by a mild clinical presentation including asymptomatic or delayed malaria cases and low parasitic 
levels. These characteristics may be
time exposed to stable malaria transmission. Malaria cases among immigrants, even asymptomatic 
patients with sub-microscopic parasitemia, could increase the risk of transmission and cause the 
reintroduction  of  malaria  in  certain  areas  that  have  adequate  vectors  and  climate  conditions. 
Moreover, imported malaria cases in immigrants can also play an important role in the non
transmission out of endemic areas, through blood transfusions, organ
transmission or occupational exposures. Consequently, outside of endemic areas, malaria screening 
should be carried out among recently arrived immigrants coming from malaria endemic countries. 
The aim of screening is to reduce the risk of clinical malaria in the individual as well as to prevent 
autochthonous transmission of malaria in areas where it has been eradicated. 
Introduction. Malaria continues to present one of the 
major  challenges  to  global  public  health  with  an 
estimated  225  million  clinical  cases  and  more  than 
700000  deaths  in  2009,  mostly  in  children  under  5 
years old from sub-Saharan Africa.
1 In Europe, malaria 
is  eradicated  in  almost  all  countries  of  the  World 
Health  Organization  European  Region  except  for 
Azerbaijan,  Georgia,  Kyrgyzstan,  Tajikistan  and 
Turkey.
1
In 2010 there were 47.3 million foreign
in the European Union (EU), corresponding to 9.4% of 
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The proportion of imported malaria cases due to immigrants in Europe has increased 
during the lasts decades, with higher rates associated with settled immigrants who travel to visit 
friends and relatives (VFRs) in their country of origin. Cases are mainly due to 
Saharan Africa is the most common origin. Clinically, malaria in immigrants is characterised 
by a mild clinical presentation including asymptomatic or delayed malaria cases and low parasitic 
levels. These characteristics may be explained by a semi-immunity acquired after long periods of 
time exposed to stable malaria transmission. Malaria cases among immigrants, even asymptomatic 
microscopic parasitemia, could increase the risk of transmission and cause the 
ntroduction  of  malaria  in  certain  areas  that  have  adequate  vectors  and  climate  conditions. 
Moreover, imported malaria cases in immigrants can also play an important role in the non
transmission out of endemic areas, through blood transfusions, organ transplantation or congenital 
or occupational exposures. Consequently, outside of endemic areas, malaria screening 
should be carried out among recently arrived immigrants coming from malaria endemic countries. 
e the risk of clinical malaria in the individual as well as to prevent 
autochthonous transmission of malaria in areas where it has been eradicated. 
Malaria continues to present one of the 
major  challenges  to  global  public  health  with  an 
estimated  225  million  clinical  cases  and  more  than 
700000  deaths  in  2009,  mostly  in  children  under  5 
In Europe, malaria 
is  eradicated  in  almost  all  countries  of  the  World 
Health  Organization  European  Region  except  for 
Azerbaijan,  Georgia,  Kyrgyzstan,  Tajikistan  and 
In 2010 there were 47.3 million foreign-born people 
in the European Union (EU), corresponding to 9.4% of 
the  total  population.  The  majority  of  them,  31.4 
million,  were  born  in  non
million were born in another EU Member State. Data 
about those coming from endemic malarial countries 
scarce.  Estimates  indicate  that  more  than  5  million 
African immigrants could be living in Europe. Among 
them, about two thirds are from North Africa (Algeria, 
Morocco  and  Tunisia)  and  the  rest  are  from  Sub
Saharan  Africa  (SSA),  mostly  from  West  Africa 
(Ghana, Nigeria and Senegal). About 4 million come 
from South East Asia and nearly 2.2 million from Latin 
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The proportion of imported malaria cases due to immigrants in Europe has increased 
during the lasts decades, with higher rates associated with settled immigrants who travel to visit 
due to P. falciparum and 
Saharan Africa is the most common origin. Clinically, malaria in immigrants is characterised 
by a mild clinical presentation including asymptomatic or delayed malaria cases and low parasitic 
immunity acquired after long periods of 
time exposed to stable malaria transmission. Malaria cases among immigrants, even asymptomatic 
microscopic parasitemia, could increase the risk of transmission and cause the 
ntroduction  of  malaria  in  certain  areas  that  have  adequate  vectors  and  climate  conditions. 
Moreover, imported malaria cases in immigrants can also play an important role in the non-vector 
transplantation or congenital 
or occupational exposures. Consequently, outside of endemic areas, malaria screening 
should be carried out among recently arrived immigrants coming from malaria endemic countries. 
e the risk of clinical malaria in the individual as well as to prevent 
autochthonous transmission of malaria in areas where it has been eradicated. 
the  total  population.  The  majority  of  them,  31.4 
million,  were  born  in  non- EU  countries,  while  16 
million were born in another EU Member State. Data 
about those coming from endemic malarial countries is 
scarce.  Estimates  indicate  that  more  than  5  million 
African immigrants could be living in Europe. Among 
them, about two thirds are from North Africa (Algeria, 
Morocco  and  Tunisia)  and  the  rest  are  from  Sub-
Saharan  Africa  (SSA),  mostly  from  West  Africa 
Ghana, Nigeria and Senegal). About 4 million come 
from South East Asia and nearly 2.2 million from Latin Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
America.
2
Imported malaria is defined as an infection acquired 
in  a  malaria  endemic  area  but  diagnosed  in  a  non-
endemic country. The malaria Programme of the WHO 
European  Region  annually  collects  data  of  malaria 
cases from 51 countries in the region. It reported an 
eight-fold increase in the number of imported malaria 
cases  between  1972  and  1988  (from  1500  to  12000 
cases), followed by a more gradual rise in 2000 (15500 
cases).  Most  of  the  cases  were  imported to  Western 
Europe,  with  France,  the  United  Kingdom  (UK), 
Germany and Italy accounting for more than 70% of all 
cases.
3 Although,  in  the  last  decade  data  from  the 
World  Health  Organization  (Figure  1)  has  shown  a 
progressive  decrease  in  the  global  incidence  of 
imported malaria in most European countries,
4 despite 
a  slight  rise  in  cases  reported  from  2008.
5 Several 
published studies have corroborated such decreases in 
certain  European  countries  such  as  the  Netherlands
6
and the UK
7 which could be explained by a reduction 
in the global malaria transmission in SSA countries. 
Today, the profile of immigrants is changing with 
higher  rates  of  immigrants  from  southern  (malaria-
endemic)  areas  moving  to  northern  (malaria  free) 
industrialised  areas  of  the  world.
3 The  proportion  of 
imported malaria cases due to immigrants  in  Europe 
has increased during the last few years from 14% in 
research published more than 10 years ago, to 86% in 
more  recent  studies.
8 On  pooling  the  reports,  nearly 
43%  of  malaria  cases  registered  in  key  European 
centres occurred in non-nationals. The rates of malaria 
are  much higher in  settled immigrants  who travel to 
visit friends and relatives (VFRs) in their country of 
origin. They can account for up to 70% of the cases in 
several reports.
9,10
Methods.  A  literature  review  was  conducted  using 
MEDLINE,  EMBASE,  Web  of  Science  and  the 
Cochrane Library database. The review included case 
studies, reviews and expert opinion. Search was based 
on published articles on imported infectious diseases in 
Fig 1: Imported malaria cases in Europe. Data from WHO Regional 
Office for Europe.
general and specifically malaria. Only those including 
data relating to immigrants (adult and paediatric) and 
based  in  European  countries  were  included.  A  table 
with  the  most  relevant characteristics  of  imported 
malaria among immigrants in Europe was created. Data 
referring to visiting friends and relatives (VFRs) and to 
refugees was not included. The selection criterion for 
including articles was based on the subjective opinion 
of the authors who considered article relevancy to the 
current research. 
Imported  malaria  in  immigrants  and  in 
immigrant-travellers (VFRs)
Most  of  the  imported  malaria  cases  among 
immigrants  in  Europe  are  due  to  P.  falciparum and 
SSA, in particular West Africa, is the most common 
origin.
11-15 The incidence of infection by P. ovale and 
mixed infections is very similar to the incidence found 
in West Africa, which is probably due to the very high 
number  of  immigrants  from  these  areas.  Data  from 
several  of  the  selected  published  reports  about 
imported  malaria  among  immigrants  in  different 
European countries is summarised in Table 1.
Children account for around 15-20% of all imported 
malaria cases in  Europe and are  increasing, as more 
children travel. Similarly as in adults, P. falciparum is 
the most frequently identified species and SSA is the 
most  common  origin.
8-16 When  comparing  clinical 
malaria among adults and children, the latter are less 
likely  to  complain  of  chills,  arthralgia/myalgia  or 
headaches. Instead they are more likely to present with 
non-specific  symptoms  or  with  gastrointestinal 
symptoms. They also have hepatomegaly and jaundice 
more often than adults.
16 In general, children seem to 
have  a  higher  risk  of  severe  malaria  than  adults 
worldwide.  For  imported  cases,  the  risk  factors  for 
developing  severe  malaria  include  young  age  (<  5 
years), delayed diagnosis (probably due to cultural and 
language barriers that make it difficult to access health 
care systems) and non-immunity to malaria. 
There is a specific group of immigrants who, once 
settled in the host country, travel to their countries of 
origin to visit friends and relatives (VFRs). They have 
been  described  as  a  special  risk  group  for  certain 
travel-related  illnesses, especially infectious diseases, 
when  compared  to  other  types  of  travellers.  This  is 
because  they  usually  travel  to  high-risk  destinations, 
for longer periods of time and usually do not seek pre-
travel advice.
17-19 This is especially significant in the 
case  of  malaria,  where  returned  VFRs  make  up  the 
largest proportion of malaria cases reported in  many 
developed  countries
15 mainly  due  to  P.  falciparum 
(75.8%)  and  almost  exclusively  in  patients  from 
SSA.
12,20,21 In a Spanish report, they accounted for 37% 
of  malaria  cases  notified  during  the  study  period.
12
Among UK surveillance data of imported malaria from Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
Table 1. Data from several published European series of imported malaria by immigrants in different European countries.
Author.
Country. Year
Nº of 
cases
Adults
Children Area of origin Malaria species Severe cases
Espinosa-Vega E et 
al.
75
Spain, 2011.
20 11 Adults
9 Children
19 SSA (11 Central Africa; 8 
West Africa), 1 America 18 P.falciparum, 2 P.vivax 1
Antinori S et al.
76
Italy 2011. 35 35 Adults
NS general data from different 
groups (75.3% Africa, 10.7% 
Asia, 7.7% Indian 
Subcontinent, 4.6% South-
America, 1.5% Middle East).
NS general data for different 
groups (78.3% P.falciparum, 
16.5% P.vivax, 3.1% P.ovale, 
0.3% P.malariae, 1.7% mixed 
infections)
NS general data 
for different 
groups 15% 
criteria for severe 
malaria.
Gracía-Villarrubia 
M et al.
77
Spain 2011. 
55 55 Children
NS general data from different 
groups (83.9% Africa, 8.6 % 
Asia, 1.7 America)
NS general data for different 
groups (69.5 P.falciparum, 14.4 
P.vivax, 5.7% P.ovale, 4.6 P 
malariae, 2.9% mixed, 2.9% 
P.spp).
0
Arnáez J et al.
78
Spain, 2010.  46 46 Children 45 SSA, 1 Latin America 41 P.falciparum, 5 mixed 
infections (NS) 0
Rey S et al.
79
Spain, 2010  19 19 Adults NS general data for different 
groups 98.2% SSA, 1.8% Asia.
NS general data for different 
groups (94.7% P.falciparum; 
5.3% P.ovale)
0
Pistone T et al.
71
France, 2010
NS general data for different 
groups 82.9% ASS
NS general data from different 
groups (82 % P.falciparum, 6% 
P.ovale, 8% P.vivax and 2% 
P.malariae).
NS
Mascarello M et 
al.
10
Italy, 2009 
35 35 Adults
SSA: 34 West Africa. 1 other 
East, Central or Southern 
African countries
All P.falciparum 0
Monge-Maillo et 
al.
25
Spain, 2009
212
69 Children
15 Young 
Adults
128 Adults
199 SSA, 13 Latin America
128  P.falciparum, 14  P.vivax., 
13 P.malariae.,10  P.ovale., 39 
P.spp.,8 mixed infections (5 
P.falciparum & P.malariae; 2 
P.falciparum & P.ovale; 1, 
P.malariae & P.ovale
NS
Mascarello M et 
al.
15
Italy, .2008 50 30 Adults
20 Children
NS general data from different 
groups ( 94.5% Africa, 4.5% 
Asia, 1% Oceania and Central 
and South America)
NS general data from different 
groups (76.8% P falciparum, 
9.5% P.ovale, 5.3%, P.vivax and 
2.4% P.malariae).
2 (1 adult and 1 
children)
Millet JP et al.
12
Spain, 2008. 106
NS general 
data from 
different 
groups 
(12% were 
children)
98 SSA, 4 Asia, 4 Latin 
America.
NS general data from different 
groups (81.6% P.falciparum)  0
Guedes S et al.
80
Findland, 2008. 201
145 
Children
56 Adults
120 Africa, 19 South East Asia, 
72 Unknown
NS general data from different 
groups (61% P.falciparum, 22% 
P.vivax, 10% P.ovale, 2%,
P.malariae).
Martínez-Baylach J 
et al.
81
Spain, 2007.
5 5 Children SSA 3 P.falciparum, 1 P.vivax, 1 
P.malariae 0
Driessen GJ et al.
14
Netherlands,  2007 8 8 Children
NS genera data from different 
groups. (84.4% SSA, 15.6% 
Asia)
NS general data from different 
groups (81% P.falciparum, 3% 
P.ovale, 13% P.vivax, 3% 
P.vivax & P.falciparum)
Rojo-Marcos G et 
al.
13
Spain, 2007 
46
NS general 
data from 
different 
groups ( 
42% 
children)
SSA
NS general data from different 
groups (89% P. falciparum; 7% 
P.ovale; 4% P. malariae)
NSMediterr J Hematol Infect Dis 2012; 4: Open Journal System
Spinazzola F et al.
82
Italy, 2006 137 137 Adults
NS general data from different 
groups ( 50.3% West Africa, 
28.4% East Africa, 9.1% South 
Africa, 8.3% Asia, Central or 
South America 2.4%,)
NS general data from different 
groups. (77.5% P.falciparum, 
18.1% P. vivax, 1.4% P ovale, 
0.4% P.malariae, 2% mixed 
infections )
Overall rate of 
severe malaria 
was 11.6% for all 
groups. Among 
immigrants 2 
patients died-
1.5%).
Ladhani S et al.
83
United Kingdom, 
2006 55 55 Children
NS general data from different 
groups (84% SSA, 15% Indian 
subcontinent))
NS general data from different 
groups. (77% P.falciparum, 14 
% P. vivax, 6% P.ovale, 3% 
P.malariae)
0
Baas MC et al.
84
The Netherlands, 
2006
26 26 Adults
NS general data from different 
groups (86% SSA, 7% Asia, 
18% Central and South 
America))
NS data from different groups 
(82 % P.falciparum, 9.3% 
P.vivax, 5% P.ovale, 2 % 
P.malariae).
NS
Chalumeau M et 
al.
85
France, 2006
7 7 children SSA 7 P.falciparum NS
Ladhani S et al.
86
United Kingdom , 
2003
38 38 children 34 SSA, 4 Indian subcontinent
NS data from different groups. 
(91 % P.falciparum, 5.7% 
P.vivax, 2.4% P.ovale, 0.5 %, 
P.falciparum & P.vivax, 
P.falciparum & P.ovale.
NS data from 
different groups 
(7.1% severe 
malaria)
Huerga H et al.
87
Spain , 2002. 56 56 children SSA
43 P.falciparum, 2 P.malariae, 
2 P.ovale, 5 mixed (3 
P.falciparum & P.malariae, 1 
P.malariae & P.ovale, 1 
P.falciparum & P.ovale)
0
Huerga H et al.
88
Spain, 2001 44 44 children NS general data from different 
groups (98% SSA, 2% LA)
NS general data from different 
groups (78% P.falciparum, 12% 
P.malariae, 8% P.ovale, 2% 
P.vivax)
1
Matteelli A et al.
89
Italy, 2001  22 22 Adults Asia (China) 20 P.falciparum, 1 P.ovale, 1 
P.falciparum/P.ovale  7
NS: not specified. SSA: Sub-Saharan Africa
1978 to 2006, 64.5% of the cases were VFRs 
21. The 
GeoSentinell report  published  in  2006  found  that 
immigrant VFRs who travelled to SSA had more than 
eight times the odds of receiving a diagnosis of malaria 
than a tourist who visited this region. Immigrant VFRs 
also  had  more  than  twice  the  odds  of  receiving  a 
diagnosis of malaria after travel to Asia and more than 
three times the odds after travel to Latin America when 
compared with tourist travellers.
20
The higher risk VFRs have of acquiring malaria is 
due to diverse factors. First of all they travel to high 
malaria  endemic  areas.  Among  the  different  reports 
published about VFRs, the most common origin was 
SSA.
12,  20,  21 Moreover, they usually travel during the 
Northern  Hemisphere’s  summer  months,  which 
coincide with the rainy season in West Africa and with 
monsoon season in the Indian subcontinent. VFRs are 
also  more  likely  to  be  travelling  to  rural  areas  and 
destinations  not  developed  for  tourism,  often  with  a 
poor  health  infrastructure.  They  also  usually  stay  at 
their destination for long periods of time.
22
VFRs  commonly  believe  they  are  immune  to 
malaria,
17 but such immunity seems to disappear some 
years  after  arriving  in  Europe.  This  makes  them  as 
vulnerable  as  other  travellers  to  developing 
symptomatic and even severe malaria when travelling 
“home”. Moreover, VFRs are more likely to travel with 
small children or while pregnant when compared with 
other types of travellers. In both these cases, VFRs are 
groups with a higher risk of contracting severe malaria. 
The low perception of risk makes them rarely seek pre-
travel advice. When advice is sought, it is more likely 
to be from a general practitioner who may not be up to 
date on pre-travel recommendations. This means that 
anti-malarial  prophylaxis  is  used  less  frequently  or 
taken incorrectly.
22 Cost may also be an impediment to 
taking antimalarials. This may lead people to purchase 
the drugs at their destination where the quality of the 
drug may be substandard. In other cases no pre-travel 
advice is sought because travel is undertaken at the last 
minute  in  order  to  attend  family  events  such  as 
marriages, funerals or to visit sick relatives. Sometimes 
language and cultural barriers may prevent VFRs from 
seeking medical advice.
23
Semi-Immunity  to  Malaria  Among  Immigrants. 
Malaria  in  immigrants  is  characterised  by  milder 
clinical  presentation,  lower  parasitic  levels,  shorter 
time for parasite clearance after treatment and shorter 
fever  duration  than  malaria  in  travellers.
15,24 Even Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
asymptomatic  malaria  cases  among  recently  arrived 
immigrants  coming  from  African  malaria  endemic 
countries have been described. In a Spanish series on 
imported  infectious  diseases  by  immigrants,  among 
SSAs 7.1% of malaria cases due to P. falciparum were 
asymptomatic at the moment of diagnoses.
25 A study 
conducted  in  Italy  to  determine  the  prevalence  of 
malaria  among  asymptomatic  SSA  immigrants 
assessed by nucleic acid sequence based amplification 
found a 31.8% prevalence of malaria.
26
Much  more  is  known  about  the  prevalence  of 
malaria and about the number of asymptomatic cases 
among  refugees.  This  is  probably  due  to  established 
protocols on screening for infectious diseases that are 
required of refugees to enter certain host countries. The 
reported prevalence of asymptomatic malaria in SSA 
refugees  screened  post  arrival  ranges  from  2.4%  to 
31.8%.
27-29 Although  studies  have  evidence  showing 
the role of asymptomatic Plasmodium spp infection in 
populations resident in Latin America, less is known 
about imported asymptomatic cases among immigrants 
or refugees from the region.
30, 31
Imported malaria cases among immigrant children 
coming  from  endemic  malaria  countries  can  also  be 
linked  to  milder  symptoms  than  those  in  child 
travellers born in non- endemic areas.
15 Even evidence 
of asymptomatic cases among immigrant children has 
been published. Most reported data for newly arrived 
SSA refugee children who present with malaria shows 
a  prevalence  of  6%  to  32%  with  high  rates  of 
asymptomatic cases.
32, 33, 34
Another characteristic  of imported  malaria among 
immigrants are the cases of late clinical presentation of 
P. falciparum infections. Most P. falciparum infections 
occurred in the first three months after arrival, with the 
delayed  onset  of  clinical  malaria  characteristics  of 
other  Plasmodium species.  Cases  of  prolonged  P. 
falciparum malaria have been described two,
35 four,
36
or even eight years
37 after living outside of an endemic 
area.  In all  of these  cases other  risk factors  such as 
travel  to  other  malaria  endemic  areas,  blood 
transfusions,  visits  to  an  airport  or  contact  with  a 
person suffering from malaria had been excluded. A 
case control study performed in France tried to identify 
the incidence and the factors associated with prolonged 
P.  falciparum infection  out  of  endemic  area.  They 
analysed 2680 patients who had travelled or lived in 
malaria endemic regions and that were diagnosed with 
a  P.  falciparum infection.  Case  patients  had  an 
infection diagnosed > 59 days after arrival in France, 
and control patients had infections detected ≤ 30 days 
after  their  arrival.    Late  infections  were  detected  in 
2.3% of the patients with a median diagnoses delay of 
5  months  (interquartile  range  3-9  months).  Three 
independent  factors  were  positively  associated  with 
prolonged P. falciparum infections, these were: being a 
first arrival immigrant, being a pregnant woman, and 
taking  mefloquine  prophylaxis.
38 Undoubtedly  many 
more studies are needed to determine which factors can 
condition a late presentation of clinical malaria. Other 
cases  of  late  P.  falciparum  malaria  infections  have 
been  published,  but  these  studies  found  other  risk 
factors, such as the recent arrival of a member of the 
family from a malaria endemic area who could have 
transported an infected Anopheles in their luggage.
39, 40
Asymptomatic malaria cases or clinical symptoms 
long  after  arrival  may  be  explained  by  a  semi-
immunity  status  in  the  migrant.  This  semi-immunity 
seems to be related to prolonged and intense exposure 
and is usually acquired in areas with persistent malaria 
transmission  as  well  as  in  areas  of  seasonal 
transmission.
41,42 Immunity  to  malaria  infection  is 
relatively  slow  to  develop  and  incomplete,  although 
immunity to death is acquired more quickly and may 
be  important  after  a  single  episode.  This  semi-
immunity  does  not  avoid  the  infection  and  the 
establishment  of  peripheral  blood  parasitemia,  but 
seems to protect against several malaria infections. So, 
in general, people from malaria endemic countries may 
have sub microscopic levels of parasitemia, but not feel 
ill or may present atypical features of malaria.
43
The mean time semi-immunity persists after leaving 
the  transmission  area  has  not  yet  been  clearly 
established.  Malaria  immunity  has  been  reported  to 
rapidly wane after the end of expose to the parasite, 
which  suggests  that  continued  exposure  to  malaria 
antigens seems to be required. Nor is there agreement 
on what components of immunity to malaria are lost 
without exposure, generally this loss in identified only 
by the fact that such people do experience symptomatic 
infections.
44 However,  a  study  conducted  in  France 
gives  evidence  that  malaria  among  African  adult 
immigrants is less severe (lower parasite density and 
lower frequency of severe and complicated diseases) 
and more readily cured than in Europeans, even more 
than 14 years after living out of an endemic area.
45 An 
in vitro study also showed that humoral and cellular 
responses to defined P. falciparum antigens persisted 
in migrants from West Africa who spent up to 13 years 
in France without travelling to their country of origin.
46
This is consistent with the results of two observational 
studies  in  the  highlands  of  Madagascar  (which  is  a 
non-malaria  endemic  area)  during  the  1987  malaria 
outbreak. Patients who were more than 40 years old, 
who  had  spent  their  childhood  in  malaria 
hyperendemic  areas  before  control  programmes  for 
malaria  existed,  were  found  to  be  more  protected 
against clinical P. falciparum infection than  younger 
patients. They also had a stronger humoral and cellular 
immune  response  to  P.  falciparum antigens.
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persistence of the semi-immunity is especially relevant 
in  VFRs.  If  such  immunity  is  lost,  immigrants  who 
travel to their country of origin would have the same 
risk  as  travellers  born  in  non-endemic  countries  of 
suffering severe malaria.
Migration and Risk of Induced and Reintroduced 
Malaria.  Migration  could  increase  the  risk  of 
transmission  and  reintroduction  of  malaria in  certain 
areas  where  it  has  previously  been  eradicated. 
Adequate  climate  conditions  and  the  presence  of 
malaria vectors in certain countries could help create a 
local  vectorial  transmission  and  a  reintroduction  of 
malaria.
48,49 Moreover,  asymptomatic  patients  with 
sub-microscopic  parasitemia  are  also  capable  of 
infecting  mosquitoes,  and  are  thus  considerate  as 
reservoirs of malaria.
50
Malaria cases imported by immigrants can play an 
important role in the non-vectorial transmission out of 
endemic  areas  through  other  mechanisms  of 
transmission  such  as  blood  transfusions,  organ 
transplantation,  congenital  transmission  or 
occupational exposure.
51,52
Data  on  the  frequency  of  transfusion  transmitted 
malaria in non-endemic countries shows a rate of about 
0.2% and the most frequently associated species are P.
falciparum, P. malariae and P. vivax.
53,54 In most of the 
published cases the donor was foreign born and came 
from an endemic area. Among five cases reported in 
the UK, four of the donors came from a SSA country; 
the fifth case was a UK traveller to Africa. In all cases 
P.  falciparum was  the  isolated  species.
53 Another 
interesting  case  of  transfusion  transmitted  P. 
falciparum malaria occurred in France: the donor also 
came from SSA with the peculiarity that he had been 
living in France for four years with no history of fever 
or illness.
51
Malaria is an unusual complication of solid-organ 
transplantation in  non-endemic  countries. Most cases 
have  been  described  after  renal  transplantation
52,55,56
with  a  few  cases  reported  after  heart
57 or  liver 
transplantations.
52,58,59 Any species of Plasmodium may 
be  involved.
60 Although  there  are  cases  where  the 
donor was a traveller to an endemic area,
58 in most of 
the  published  cases  donors  are  immigrants  coming 
from a country with a high prevalence of malaria. In 
one case of P. falciparum transmission through a heart 
transplant in France, the donor came from SSA and had 
been asymptomatic during the 15 months she lived in 
the host country.
57 In a published case of a multi-organ 
donation  in  Germany  P.  vivax was  transmitted  to 
receptors: the  donor was an  immigrant  coming  from 
SSA who had lived in Germany for the last 18 months 
and had been asymptomatic during all of that time.
61
Congenital malaria out of endemic areas is rare and 
predominantly  seen  in  infants  of  recently  arrived 
mothers. Most infants develop symptoms at the age of 
approximately one month. Because the initial clinical 
presentation of congenital malaria can be very similar 
to  that of  neonatal  sepsis, physicians  must be aware 
and suspect Plasmodium infection among those born to 
immigrant mothers.
62
In Europe, where malaria has been eradicated since 
1975,  Anopheles  spp.  mosquito  vectors  remain 
prevalent in parts of Southern and Central Europe. In 
fact, transmission of malaria to local residents has been 
reported over the last 10 years, and the hypothesis of 
malaria  reintroduction  has  also  recently  been 
confirmed.  In  Greece,  in  2011,  at  least  33 
autochthonous  malaria  cases  due  to  P.  vivax were 
recorded.
63,64 In Spain another case of autochthonous P. 
vivax infection was detected.
65 We must also consider 
global climate change, which could help spread malaria 
to northern latitudes.
66 However, the real possibility of 
a European country becoming an endemic malaria area 
seems  quite  small.  Surveillance  and  public  health 
measures would probably avoid such situation. 
Screening for Malaria Among Immigrants . 
The evidence of asymptomatic malarial infections or 
the late clinical presentation of these infections, which 
can  be  reservoir  of  malaria  added  to  other  possible 
mechanisms of transmission out of endemic area raises 
the need of systematic screening processes. Screening 
has  been  more  established  for  refugees,  where 
approaches  to  mitigate  the  risk  of  malaria  in  these 
populations  include  mass  antimalarial  treatment  pre-
departure or on arrival and screen and treat strategies 
for targeted groups. The US Center for Disease Control 
(CDC)  issued  new  guidelines  in  2010  for  refugees 
arriving  from  SSA  which  recommend  presumptive 
treatment  either  pre-departure  or on  arrival.
67 Recent 
guidelines from the  Australian Society for  Infectious 
Disease include malaria testing and treatment at both 
pre-departure  and  at  the  post-arrival  health 
assessment.
68 These  measures  should  probably  be 
extrapolated  to  recently  arrived  immigrants  coming 
from malaria endemic countries. Screening for malaria 
among  this  population  could  constitute  an  effective 
public  health  measure,  especially  when  a  high 
proportion of immigrants can be asymptomatic.
69
The effectiveness of strategies based on screening at 
arrival  is  heavily  dependent  on  the  proportion  of 
refugees  and  immigrants  who  receive  systematic 
assessment  by  a  clinic  with  specific  expertise  in 
imported  infectious  diseases  and,  the  diagnostic 
method  used.
27 In  fact,  diagnosing  asymptomatic 
patients  requires  techniques  that  enable  the 
measurement of infections with a very low density of 
parasitemia.  The  sensitivity  of  a  malaria  test  is  the Mediterr J Hematol Infect Dis 2012; 4: Open Journal System
probability that at least one parasitized red blood cell is 
detected. This is directly related to the volume of blood 
that the test can screen and the density of parasites in 
the  blood  sample.
70 With  microscopy  techniques  the 
volume of blood examined is 0,06-0,2 μL, while PCR 
uses  several  micro-litres,  giving  theoretical  limits  of 
detection  of  5-16  parasites/μL  by  microscopy  and 
0.002-1  parasites/μL  by  PCR.
71 A  systematic  review 
and meta-analysis of surveys of endemic populations in 
which P. falciparum prevalence is measured by both 
microscopy  and  PCR  techniques  indicated  that  the 
prevalence of infection measured by microscopy was, 
on average, 50.8% of that measured by PCR.
72 A study 
conducted  in  the  United  States  comparing  a  rapid 
antigen  capture  enzyme  assay  with  PCR  for  the 
screening in SSA refugees showed that the sensitivity 
and  specificity of  the  rapid antigen  assay were  22% 
and  66%  respectively.
73 In  Canada  two  different 
antigen  detection  tests  were  also  evaluated:  ICT 
Malaria (sensitivity 37.5% and specificity 100%) and 
OptiMAL (sensitivity 29.1% and specificity 95.6%).
27
In both studies microscopy was also analysed without 
better outcomes. Therefore, PCR is probably by far the 
most powerful tool for such surveillance. 
Moreover, taking into account the long periods of 
time after arrival that parasitemias seem to persist, we 
should consider whether screening should be offered 
not  only  to  recently  arrived  immigrants  but  also 
immigrants settled in the host country for some time.
69
In  fact,  a  mathematical  modelling  has  estimated  the 
maximum  duration  of  P.  falciparum infection  after 
interruption of transmission in about 4 years.
74
Summary. Malaria imported by immigrants makes up 
a significant proportion of the cases diagnosed out of 
endemic areas. They are mostly due to P. falciparum
and  found  among  those  coming  from  West  Africa. 
Malaria  in  immigrants  is  characterised  by  a  mild 
clinical presentation, low parasitic levels; short parasite 
clearance time after treatment and, short fever duration. 
In  fact,  a  high  proportion  of  immigrants  may  be 
asymptomatic  or  present  clinical  malaria  long  after 
arrival in the host country. Such characteristics seem to 
be explained by the semi-immunity to malaria acquired 
after living in endemic areas. 
In parallel with migration, immigrants settled in the 
host country  increasingly  travel  to  their  country  of 
origin to visit friends and relatives (VFRs). They have 
been described as a special risk group for certain travel 
related  infectious  diseases  when  compared  to  other 
types of travellers. Malaria is one of the most frequent 
diagnoses among them, mainly due to  P. falciparum 
and almost exclusively in patients from Sub-Saharan 
Africa (SSA). 
Congenital  transmission  or  transmission  due  to 
blood  transfusion  or  organ  transplantation  out  of 
endemic  area  has  been  described.  Furthermore, 
adequate  climate  conditions  and  the  presence  of 
malaria  vectors  in  certain  European  countries  could 
contribute  to  local  vectorial  transmission  and  a 
reintroduction of malaria in  areas where it  had been 
eradicated. 
Consequently,  out  of  endemic  areas,  strategies  to 
control  imported  malaria  by  immigrants  should  be 
multifaceted.  Firstly,  screening  for  malaria  among 
recently  arrived  immigrants  from  malaria  endemic 
countries should be performed. The aim of this is to 
reduce the risk of clinical malaria in the individual as 
well  as  to  prevent  autochthonous  transmission  of 
malaria  in  areas  where  it  has  been  eradicated.  The 
evidence  of  persistent  asymptomatic  parasitemia 
suggests that screening time after arrival could also be 
considered.  Secondly,  the  relevance  of  imported 
malaria  cases  among  VFRs  highlights  the  need  of 
preventive  health  promotion  strategies  culturally 
adapted and focused on pre-travel advice. 
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